Whole exome sequencing and data analysis

JL Jie Li
PJ Phillip M. Galbo, Jr.
WG Weida Gong
AS Aaron J. Storey
YT Yi-Hsuan Tsai
XY Xufen Yu
JA Jeong Hyun Ahn
YG Yiran Guo
SM Samuel G. Mackintosh
RE Ricky D. Edmondson
SB Stephanie D. Byrum
JF Jason E. Farrar
SH Shenghui He
LC Ling Cai
JJ Jian Jin
AT Alan J. Tackett
DZ Deyou Zheng
GW Gang Greg Wang
request Request a Protocol
ask Ask a question
Favorite

Genomic DNA of ZM-induced primary tumors, derived from bone marrow of leukemic mice and followed by a quick puromycin selection to enrich ZM-expressing leukemic blasts, was extracted using the PureLink Genomic DNA Mini Kit (Invitrogen, cat# K182002). Genomic DNA of the ZM-infected HSPCs, which were used in bone marrow transplantation for inducing AML in mice, was used as control for calling potential spontaneous mutations acquired during the course of AML development in vivo. Library preparation, sequencing, and data analysis were carried out by Novogene. In brief, sequencing libraries were generated using the Agilent SureSelectXT Mouse All Exon kit. After 100X whole exome sequencing, BWA was utilized to map the paired-end clean reads to the mouse reference genome mm10. SNPs and InDels were detected and filtered (total counts ≥ 10) using GATK software. The tool muTect and Strelka were used to call somatic SNPs and InDels in tumor samples, respectively. Variants were annotated with ANNOVAR.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A